The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis.
BACKGROUND: Multiple myeloma (MM) is a clonal proliferative disorder of plasma cells with limited curative options. Hepatitis B (HBV) and hepatitis C (HCV) viruses have been implicated in the development of various hematological malignancies, but their association with MM remains unclear. This systematic review and meta-analysis aimed to investigate the risk of MM in individuals with HBV and HCV infections.
METHODS: A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, Embase, and additional sources for cohort and case-control studies published between January 1990 and January 2025. The relative risk (RR) of developing MM in individuals with HBV and HCV infections was pooled using a random-effects model. Subgroup analyses were performed based on age, geographic region, and diagnostic method. The Newcastle-Ottawa Scale (NOS) was used to assess study quality. Statistical heterogeneity was evaluated using the I² statistic, and publication bias was assessed using Egger's test.
RESULTS: Seventeen studies, comprising 1 cohort and 16 case-control studies, were included. Nine studies examined the association between HBV and MM, yielding a pooled RR of 1.25 (95% CI: 0.99-1.58) with moderate heterogeneity (I² = 56.52%). Fifteen studies evaluated the association between HCV and MM, with a pooled RR of 1.84 (95% CI: 1.27-2.67), indicating a higher risk in HCV-infected individuals. Subgroup analysis revealed a stronger association in European populations for both HBV (RR: 1.67, 95% CI: 1.05-2.66) and HCV (RR: 2.27, 95% CI: 1.21-4.25). No significant publication bias was detected for either HBV or HCV analyses.
CONCLUSION: HBV and HCV infections are associated with an increased risk of developing multiple myeloma, with HCV demonstrating a stronger association. These findings highlight the importance of screening and monitoring patients with chronic hepatitis for potential hematological malignancies, especially in high-risk regions.
Stay Informed!
